John D. Halpern - 27 Dec 2023 Form 3 Insider Report for Comera Life Sciences Holdings, Inc.

Role
Member of 10% owner group
Signature
/s/ John D. Halpern
Issuer symbol
CMRA on OTC
Transactions as of
27 Dec 2023
Net transactions value
$0
Form type
3
Filing time
08 Jan 2024, 17:33:52 UTC
Previous filing
05 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CMRA Common Stock 1,088,819 27 Dec 2023 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CMRA Warrants to Purchase Common Stock 27 Dec 2023 Common Stock 405,404 $1.23 By Trust F1
holding CMRA Warrants to Purchase Common Stock 27 Dec 2023 Common Stock 855,745 $0.6135 By Trust F1
holding CMRA Warrants to Purchase Common Stock 27 Dec 2023 Common Stock 366,748 $0.6135 By Trust F1
holding CMRA Warrants to Purchase Common Stock 27 Dec 2023 Common Stock 4,073,744 $0.0550 By Trust F1
holding CMRA 12.0% Senior Secured Convertible Notes 27 Dec 2023 Common Stock 2,036,872 $0.0550 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by John D. Halpern Revocable Trust, of which both John D. Halpern and Katherine H. Halpern are trustees.